Holen Sie sich die Stockscreener-App
8.68
0.40%
-0.02
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt IOVA?
Forum
Prognose
Aktiensplit
Iovance Biotherapeutics Inc Aktie (IOVA) Neueste Nachrichten
Iovance Biotherapeutics stock trends on sector momentum, Q2 beat - scanx.trade
NFLX: Netflix Inc Latest Stock Price, Analysis, News and Trading Ideas - Stocktwits
Why Did IOVA, AMLX And COP Stocks Surge To 52-Week Highs Today? - Stocktwits
IOVA Stock Slump Takes Wall Street, Retail By Surprise — Here’s Why - Stocktwits
After IOVA Stock’s Best Day In 2 Years, Analyst Sees Over 300% Upside: Here’s Why - Stocktwits
How Iovance Biotherapeutics Inc. (IOVA) Affects Rotational Strategy Timing - Stock Traders Daily
Iovance Biotherapeutics Stock Price Forecast. Should You Buy IOVA? - StockInvest.us
Iovance Biotherapeutics, Inc. (IOVA) Latest Press Releases & Corporate News - Yahoo Finance
Iovance Biotherapeutics, Inc. (IOVA) Latest Stock News & Headlines - Yahoo Finance
Two talks are planned in Boston and New York by Iovance leaders - Stock Titan
Iovance Biotherapeutics Inc (IOVA) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Iovance Biotherapeutics (IOVA) Stands Out with Strong Quant Rati - GuruFocus
Iovance Biotherapeutics (IOVA) Wins FDA Trial Clearance, Is The Stock Still 54% Undervalued? - Sahm
Iovance Biotherapeutics Inc. (IOVA) Peer Comparison – Compare with Others - Value Research
Zacks Industry Outlook Halozyme, Repligen, Iovance, Arcutis and Precigen - Eastern Progress
Iovance Biotherapeutics (IOVA) Reports Q2 Loss, Tops Revenue Estimates - Eastern Progress
Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4) - The Manila Times
Biotech company Iovance grants 20 new employees options with an $8.99 exercise price - Stock Titan
Iovance Biotherapeutics (NASDAQ:IOVA) Stock Price Down 5.8%Here's Why - MarketBeat
IOVA Stock Pulls Back As Biotech Momentum Cools - StocksToTrade
UBS Lifts Iovance Biotherapeutics Price Target as Cancer Drug Sales Top Expectations - TIKR.com
Iovance Biotherapeutics Stock Is Trending Friday: What's Going On? - Benzinga
Iovance Biotherapeutics grants inducement stock options to 27 new employees - scanx.trade
IOVA Stock Hits Fresh 52-Week Peak On UBS Target Hike, Melanoma Sector Optimism - Stocktwits
Iovance Shares Rise 12.5% as Analyst Price Targets Lag Behind Rally - TechStock²
Why Iovance Biotherapeutics Stock Hit 52-Week High - TradingView
IOVA Maintained by UBS -- Price Target Raised to $7.00 - GuruFocus
Iovance's Growth Outlook Clouded as Amtagvi Faces Competition Hurdles, UBS Says - marketscreener.com
META_TITLE_QUOTE - Yahoo Finance
IOVA Stock Climbs As Earnings Beat Fuels Guidance Rethink - StocksToTrade
Iovance Biotherapeutics (NASDAQ:IOVA) Marks Major Market Shift - Kalkine Media
Here's Why Iovance Biotherapeutics (IOVA) is a Great Momentum Stock to Buy - Yahoo Finance
Iovance Biotherapeutics: Breakout Quarter, Catalysts Ahead, And Competitor Updates (IOVA) - Seeking Alpha
UBS raises Iovance Biotherapeutics stock price target on revenue beat By Investing.com - Investing.com Canada
Iovance Biotherapeutics (NASDAQ:IOVA) Reaches New 12-Month HighWhat's Next? - MarketBeat
IOVANCE BIOTHERAPEUTICS INC : UBS RAISES TARGET PRICE TO $7 FROM $4 - webull.com
IOVA Stock Hits New 52-Week High As Shares Jump 14% — What Drove The Rally? - TradingView
Iovance Biotherapeutics Rallies as Strong Amtagvi Sales Keep Post-Earnings Momentum Alive - Moomoo
Iovance Biotherapeutics, Inc., Qingdao Sino-Cell Biomedicine Co., Ltd., Grit Biotechnologies, Shanghai Juncell Therapeutics, Curacell Holding Ab, Ksq Therapeutics, Sapphire Biotech, Beijing Sali Biopharmaceutical Co., Ltd. Provide Updates on Til Therapy C - marketscreener.com
symbol__ Stock Quote Price and Forecast - CNN
TIL Therapy Clinical Trial Pipeline Appears Robust With 17+ - GlobeNewswire
IOVA Stock Climbs As Amtagvi Sales Crush Q2 Expectations - timothysykes.com
Iovance Biotherapeutics (NASDAQ:IOVA) Stock Price Up 11% Following Analyst Upgrade - MarketBeat
Iovance (IOVA) Market: Closes 8.25% Higher at $7.61 for the Current Session; Chart View: the Near-Term Reference Band Stretches From $7.23 to $7.99 on the DayGamma Squeeze - Vinanet
Iovance Biotherapeutics (IOVA) Earnings Put Its Valuation Back In Focus - Sahm
Why Did AMLX, IOVA, OKE Stocks Hit 52-Week Highs Today? - Yahoo Finance
IOVA Maintained by Mizuho -- Price Target Raised to $11.00 - GuruFocus
Iovance Biotherapeutics (NASDAQ:IOVA) Given New $11.00 Price Target at Mizuho - MarketBeat
Rice Hall James & Associates LLC Acquires Shares of 1,539,840 Iovance Biotherapeutics, Inc. $IOVA - MarketBeat
Why Did IOVA Stock Gain Pre-Market Today? - Stocktwits
Mizuho Securities Maintains Iovance Biotherapeutics(IOVA.US) With Buy Rating, Raises Target Price to $11 - Moomoo
IOVA Stock Price, Quote & Chart - ChartMill
Iovance Biotherapeutics Inc : Baird Assumes C - Moomoo
GSA Capital Partners LLP Buys New Holdings in Iovance Biotherapeutics, Inc. $IOVA - MarketBeat
Bank of America Corp DE Sells 5,787,694 Shares of Iovance Biotherapeutics, Inc. $IOVA - MarketBeat
Iovance Biotherapeutics, Inc. stock Analysis: 130% Rally & Overbought Signals 2026 - The Cryptonomist
0.63%
3.49%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):